Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells

Glioblastoma is the most prevalent and aggressive primary brain tumour for which total tumour lysate-pulsed dendritic cell vaccination is currently under clinical evaluation. Glioblastoma extracellular vesicles (EVs) may represent an enriched cell-free source of tumour-associated (neo-) antigens to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Extracell Vesicles
Autors principals: Dusoswa, Sophie A., Horrevorts, Sophie K., Ambrosini, Martino, Kalay, Hakan, Paauw, Nanne J., Nieuwland, Rienk, Pegtel, Michiel D., Würdinger, Tom, Van Kooyk, Yvette, Garcia-Vallejo, Juan J.
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6713149/
https://ncbi.nlm.nih.gov/pubmed/31489145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20013078.2019.1648995
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars